Literature DB >> 19887755

Activation of PI3K-AKT pathway in oral epithelial dysplasia and early cancer of tongue.

Shinya Watanabe1, Kazumichi Sato, Yuichiro Okazaki, Morio Tonogi, Yoichi Tanaka, Gen-yuki Yamane.   

Abstract

Increasingly, cancers are being diagnosed at an early stage. Leukoplakia, a precancerous lesion, progresses to cancer in 5-10% of cases. We performed genetic analysis using cDNA microarray and immunohistochemistry in 6 patients, 3 with precancerous lesions and 3 with early tongue cancer, to evaluate the usefulness of these methods in the diagnosis of precancerous lesions and early cancer. Samples of normal epithelium, epithelial dysplasia, and cancer tissues were collected by laser microdissection, RNA was extracted, and the signals converted to numerical values. Immunohistochemical analysis was performed using antibody against phospho AKT (p-AKT), a component of the phosphoinositide 3-kinase (PI3K) signal pathway. Five genes showed a 2 times or greater level of increase in expression in epithelial tissue in comparison with in normal tissue, while 4 genes showed a 2 times or greater increase in early cancer tissues. In cancer tissues and epithelial dysplasia tissues, PI3K class III was expressed at 2.5 times and 11 times the level of that found in normal tissue, respectively. Histochemistry using p-AKT antibody revealed no positive cells in normal tissue. Positive cells were noted in the basal and parabasal cell layers, and partially in the spinous layer of epithelial dysplasia tissues, and in the spinous layer of early cancer tissues. These findings suggest that activation of the PI3K-AKT signal pathway is associated with oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887755     DOI: 10.2209/tdcpublication.50.125

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  12 in total

1.  Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivo-buccal oral cancer.

Authors:  Debodipta Das; Arindam Maitra; Chinmay K Panda; Sandip Ghose; Bidyut Roy; Rajiv Sarin; Partha P Majumder
Journal:  NPJ Genom Med       Date:  2021-05-12       Impact factor: 8.617

2.  TWIST and p-Akt immunoexpression in normal oral epithelium, oral dysplasia and in oral squamous cell carcinoma.

Authors:  Bruno-Santos de Freitas Silva; Fernanda-Paula Yamamoto; Flávia-Sirotheau Corrêa Pontes; Sérgio Elias-Vieira Cury; Felipe-Paiva Fonseca; Hélder Antonio-Rebelo Pontes; Décio-dos Santos Pinto-Júnior
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-01-01

Review 3.  Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review.

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Clin Med Insights Oncol       Date:  2013-10-31

4.  In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures.

Authors:  Walter K Schlage; Anita R Iskandar; Radina Kostadinova; Yang Xiang; Alain Sewer; Shoaib Majeed; Diana Kuehn; Stefan Frentzel; Marja Talikka; Marcel Geertz; Carole Mathis; Nikolai Ivanov; Julia Hoeng; Manuel C Peitsch
Journal:  Toxicol Mech Methods       Date:  2014-09-11       Impact factor: 2.987

5.  VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.

Authors:  Nishant Mohan; Yi Shen; Milos Dokmanovic; Yukinori Endo; Dianne S Hirsch; Wen Jin Wu
Journal:  Oncotarget       Date:  2016-08-09

6.  Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.

Authors:  Nand Kishor Roy; Javadi Monisha; Ganesan Padmavathi; H Lalhruaitluanga; Nachimuthu Senthil Kumar; Anuj Kumar Singh; Devivasha Bordoloi; Munindra Narayan Baruah; Gazi Naseem Ahmed; Imliwati Longkumar; Frank Arfuso; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2019-06-27

Review 7.  Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Authors:  Choudhary Harsha; Kishore Banik; Hui Li Ang; Sosmitha Girisa; Rajesh Vikkurthi; Dey Parama; Varsha Rana; Bano Shabnam; Elina Khatoon; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

8.  Indole-3-carbinol inhibits nasopharyngeal carcinoma cell growth in vivo and in vitro through inhibition of the PI3K/Akt pathway.

Authors:  Cheng-Gang Mao; Ze-Zhang Tao; Zhe Chen; Chen Chen; Shi-Ming Chen; Li-Jia Wan
Journal:  Exp Ther Med       Date:  2014-04-25       Impact factor: 2.447

9.  Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth.

Authors:  Zhe Ying; Madeline Sandoval; Slobodan Beronja
Journal:  Nat Cell Biol       Date:  2018-10-22       Impact factor: 28.824

10.  Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.

Authors:  Guojun Yang; Yixin Yang; Hong Tang; Kai Yang
Journal:  Cancer Sci       Date:  2020-03-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.